metricas
covid
Neurología (English Edition) Failure of monoclonal antibodies against CGRP or its receptor does not imply lac...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class
El fracaso a anticuerpos monoclonales frente a CGRP o su receptor no implica la inefectividad a otros fármacos de la misma clase terapéutica
J. Porta-Etessama,b,c,
Corresponding author
jporta@yahoo.com

Corresponding author.
, N. González-Garcíaa, Á.L. Guerrerod,e,f, D. García-Azorínd,f
a Unidad de Cefaleas, Servicio de Neurología, Hospital Clínico Universitario San Carlos, Madrid, Spain
b Departamento de Medicina, Universidad Complutense de Madrid, Madrid, Spain
c Instituto de Investigación Biomédica, Hospital Clínico San Carlos, Madrid, Spain
d Unidad de Cefaleas, Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
e Departamento de Medicina, Universidad de Valladolid, Valladolid, Spain
f Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
Read
4004
Times
was read the article
896
Total PDF
3108
Total HTML
Share statistics
Article information
ISSN: 21735808
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 130 27 157
2025 11 121 52 173
2025 10 70 15 85
2025 9 64 20 84
2025 8 50 19 69
2025 7 73 14 87
2025 6 51 16 67
2025 5 53 13 66
2025 4 53 9 62
2025 3 63 3 66
2025 2 49 9 58
2025 1 49 5 54
2024 12 29 9 38
2024 11 45 6 51
2024 10 33 9 42
2024 9 47 18 65
2024 8 47 13 60
2024 7 37 6 43
2024 6 48 8 56
2024 5 27 11 38
2024 4 24 11 35
2024 3 39 10 49
2024 2 62 11 73
2024 1 40 5 45
2023 12 54 18 72
2023 11 82 15 97
2023 10 88 22 110
2023 9 62 5 67
2023 8 43 12 55
2023 7 68 14 82
2023 6 69 22 91
2023 5 91 15 106
2023 4 76 13 89
2023 3 52 20 72
2023 2 47 22 69
2023 1 34 30 64
2022 12 48 16 64
2022 11 73 22 95
2022 10 48 24 72
2022 9 58 33 91
2022 8 46 17 63
2022 7 54 13 67
2022 6 44 21 65
2022 5 59 16 75
2022 4 52 13 65
2022 3 74 16 90
2022 2 53 13 66
2022 1 104 17 121
2021 12 60 17 77
2021 11 81 22 103
2021 10 81 49 130
2021 9 61 39 100
2021 8 29 10 39
2021 7 13 11 24
Show all

Follow this link to access the full text of the article

Article options
Tools